ACAT1 knockdown CD8+ T cells exhibit increased membrane cholesterol and enhanced TCR aggregation and signaling, which improves T-cell proliferation, function, and tumor-killing capacity [314]. The gene discussed is CD8A; the disease is neoplasm.